Cargando…

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis

Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent comorbidity in psoriasis and a risk factor for cardiovascular disease, a major cause of death among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, J.J., Kavanaugh, A., Lebwohl, M.G., Gniadecki, R., Merola, J.F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313585/ https://www.ncbi.nlm.nih.gov/pubmed/35238067 http://dx.doi.org/10.1111/jdv.18044

Ejemplares similares

Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
por: Merola, Joseph F., et al.
Publicado: (2022)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
por: Wu, Jashin J., et al.
Publicado: (2020)

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
por: Lebwohl, Mark G., et al.
Publicado: (2015)

Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management
por: De Brandt, Eveline, et al.
Publicado: (2022)

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
por: Wu, Jashin J., et al.
Publicado: (2020)

Psoriasis and Metabolic Syndrome – scientific evidence and therapeutic implications
por: Voiculescu, VM, et al.
Publicado: (2014)

Psoriasis: Overview and Diagnosis
por: Kimmel, Grace W., et al.
Publicado: (2018)

Psoriasis and Metabolic Syndrome
por: Malkic Salihbegovic, Eldina, et al.
Publicado: (2015)

Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009)

Psoriasis and Metabolic Syndrome: Comorbidities and Environmental and Therapeutic Implications
por: Peralta, Cesar, et al.
Publicado: (2019)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis
por: Bocheńska, Katarzyna, et al.
Publicado: (2020)

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
por: Singh, Sanminder, et al.
Publicado: (2018)

Links and risks associated with psoriasis and metabolic syndrome
por: Liakou, Aikaterini I, et al.
Publicado: (2015)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
por: Fu, Lisa Wenyang, et al.
Publicado: (2011)

Editorial: fixed‐dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

Management of psoriasis in adolescence
por: Fotiadou, Christina, et al.
Publicado: (2014)

Immunotargeting in the management of psoriasis
por: Kaffenberger, Benjamin H, et al.
Publicado: (2013)

Skin Patterning in Psoriasis by Spatial Interactions between Pathogenic Cytokines
por: Ringham, Lee, et al.
Publicado: (2019)

Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
por: Papp, Kim A., et al.
Publicado: (2021)

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis
por: Gottlieb, Alice, et al.
Publicado: (2020)

Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
por: Lambert, J.L.W., et al.
Publicado: (2020)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022)

Metabolic comorbidities of psoriasis (Review)
por: Branisteanu, Daciana Elena, et al.
Publicado: (2022)

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
por: Gottlieb, Alice B., et al.
Publicado: (2021)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Should biologics for psoriasis be interrupted in the era of COVID-19?
por: Lebwohl, Mark, et al.
Publicado: (2020)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Psoriasis Prevalence and Severity by Expert Elicitation
por: Papp, Kim A., et al.
Publicado: (2021)

Prevalence of Metabolic Syndrome in Patients with Psoriasis
por: Zindancı, Ilkin, et al.
Publicado: (2012)

Metabolic Syndrome and Skin: Psoriasis and Beyond
por: Padhi, Tanmay, et al.
Publicado: (2013)

Psoriasis and its Association with Metabolic Syndrome
por: Agarwal, Komal, et al.
Publicado: (2023)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

Biologic Drug Survival in Psoriasis: A Systematic Review & Comparative Meta-Analysis
por: Mourad, Ahmed I., et al.
Publicado: (2021)

Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007)

Psoriasis Pathogenesis and Treatment
por: Rendon, Adriana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m97j8kjblse39gjb4okheo2ksc